Making essential medicines available in developing countries is a pressing international problem. This wide-ranging volume focuses on the impact of TRIPS (the World Trade Organizations Agreement on Trade-Related Aspects of Intellectual PropertyMoreMaking essential medicines available in developing countries is a pressing international problem. This wide-ranging volume focuses on the impact of TRIPS (the World Trade Organizations Agreement on Trade-Related Aspects of Intellectual Property Rights), on concerns to improve access for the poor to essential medicines, and on health service delivery and research and development issues.
The complexity of the debate is highlighted from a variety of different economic perspectives - those of academics, policy-makers in wealthy and poor states, international and non-governmental organizations, and the pharmaceutical industry.